Filter by
Filters
Filter results

Date

Primary topics

All topics

Types of content

All types

Products

All products

Diseases

All diseases

General Terms

All terms

Geography

All locations

Campaigns

All campaigns

Institutions & Events

All events and institutions

Report series

All publications
Apply
Clear all filters
34 results found
In June and July 2016 MSF has been conducting vaccination campaigns in several refugee camps and settlements in Greece, targeting more than 4,600 children under fifteen years of age. This campaign aims at protecting refugee children with 10 antigens and preventing diseases such as pneumonia, which is the leading cause of childhood death. MSF calls on Pfizer and GSK to drop the price of the pneumonia vaccine (PCV) for governments and humanitarian organizations in emergency contexts.
Press release |

MSF responds to news that Gavi will release funds from pneumonia vaccine ‘Advance Market Commitment’ to first new product from a developing country manufacturer

Gavi, the Vaccine Alliance, has just announced that it will award part (US$75 million) of the remaining $262 million of the Advance Market Commitment (AMC)—a $1.5 billion fund that was launched in 2009 to pay for the introduction of ...
Tags Vaccines pneumococcal disease pneumococcal conjugate vaccine Gavi, the Vaccine AllianceSerum Institute of India
Patients and MSF staff perform a dance to welcome new members to the "six-months-meeting day" in Mbulumbuzi Health Centre for the Adolescent HIV project in Malawi, it also monitors all the girls and boy who have already joined the program.
Press release |

Pfizer and GSK’s HIV/AIDS division, ViiV, prevents children with HIV from getting needed medicine

MSF calls out ViiV Healthcare—a division of US and UK pharmaceutical corporations Pfizer and GlaxoSmithKline plus Japan’s Shionogi—for preventing children with HIV from getting child-appropriate formulations of a critical HIV medicine ...
Tags HIV/AIDS HIV/AIDS dolutegravir Clinton FoundationUNITAIDWorld Health OrganizationInternational AIDS ConferenceGlaxoSmithKlinePfizerViiV KenyaMalawiNigeriaSouth Africa